Thematic Approaches to COVID-19

Features, Transmission, Detection, and Case Studies in COVID-19 examines the effects of the virus on the body, as well as its transmission and clinical profile. This volume begins with an introduction to the virus and its pathogenesis, transmission, and avoidance, followed by sections on pulmonary and cardiovascular effects, obesity, diabetes, the liver, detection issues, and biomarkers. Vaccines and treatment are also discussed. Specific case studies covered include hypoxia, acute kidney injury, pneumonia, and neurological effects. This volume is relevant for all clinicians and scientists working to ensure the best outcomes for patients with COVID-19.Linking Neuroscience and Behavior in COVID-19 examines the effect of both the virus and the pandemic on behavior and mental health. Chapters look at the burden of the COVID-19 pandemic on those with pre-existing conditions, including Parkinson's disease and multiple sclerosis. The ongoing consequences of the pandemic on the mental health of the broad populace are discussed. As well as the neurological effects of the virus itself, chapters discuss psychological concerns including depression and anxiety. Finally, the chapters also include aspects relevant to managing care and the treatment of conditions. A broad range of conditions preceding, caused by, or emerging for the first time during the pandemic are also detailed.International and Life Course Aspects of COVID-19 describes the nuances and international variations of COVID-19 in different populations and age groups. This volume details those differences in chapters examining the effects of the virus at different life stages, including newborns, children, adolescents, and older populations. Consideration of the age-specific effects of COVID-19 on the brain are a major focus unique to this resource. International observations and global outcomes are also described. This volume is relevant for all clinicians working to ensure the best outcomes for patients with COVID-19 worldwide.Management, Body Systems, and Case Studies in COVID-19 describes the assessment and treatment of patients infected with the novel coronavirus that causes the varied symptoms of COVID-19. Detailing this multisystem disease and the organs and tissues affected, this volume features chapters on several body systems. Conditions affecting the respiratory, hematological, hepatobiliary, renal, gastrointestinal, nervous, musculoskeletal, and cardiovascular systems are addressed. The fundamental role of telemedicine during the pandemic is also discussed. This volume is relevant for all clinicians and scientists working to ensure the best outcomes for patients with COVID-19. Features, Transmission, Detection, and Case Studies in COVID-19Discusses COVID-19 biology, including pathogenesis and transmissionDescribes systemic issues caused by COVID-19, including cardiovascular effects and loss of taste and smellOutlines detection methods, biomarkers associated with severity, and disease outcomesFeatures individual chapter introductions, summaries, and case studies to provide comprehensive descriptions of COVID-19 symptoms and effectsContains chapters with key facts, dictionary of terms, summary points, applications to other areas pertinent to each chapter, and policies and proceduresDiscusses COVID-19 biology, including pathogenesis and transmissionDescribes systemic issues caused by COVID-19, including cardiovascular effects and loss of taste and smellOutlines detection methods, biomarkers associated with severity, and disease outcomesFeatures individual chapter introductions, summaries, and case studies to provide comprehensive descriptions of COVID-19 symptoms and effectsContains chapters with key facts, dictionary of terms, summary points, applications to other areas pertinent to each chapter, and policies and proceduresLinking Neuroscience and Behavior in COVID-19 Discusses the impact of the COVID-19 pandemic and the virus itself on behavior and psychologyExamines comorbidities including Parkinson's disease, neuroinflammation, and autism spectrum disordersOutlines the management and care for coexisting conditions including brain tumors, multiple sclerosis, and ischemic strokeFeatures chapters on the severe damage to the nervous system which may be caused by SARS-CoV-2 infection including myelitisContains chapters with key facts, dictionary of terms, summary points, applications to other areas pertinent to each chapter, and policies and proceduresInternational and Life Course Aspects of COVID-19 Examines COVID-19 symptoms and concerns according to ageDiscusses outcomes related to global populations and differences observed in symptomatology and careFocuses on the brain, with a look at developmental changes in pregnancy, newborns, childhood, and adolescenceDescribes mental health impacts in the older populationsFeatures individual chapter introductions and summaries to provide a comprehensive introductionContains chapters with key facts, dictionary of terms, summary points, applications to other areas pertinent to each chapter, and policies and proceduresManagement, Body Systems, and Case Studies in COVID-19 Discusses the management of multisystem symptomatology, including the effects of COVID-19 on the neurological, respiratory, hematological, hepatobiliary, gastrointestinal, and cardiovascular systemsIncludes select guidelines for clinics providing care for COVID-19 patientsFeatures individual chapter introductions, and a section on case studies to provide a comprehensive primer for each topicContains chapters with key facts, dictionary of terms, summary points, applications to other areas pertinent to each chapter, and policies and procedures INDICE: Features, Transmission, Detection, and Case Studies in COVID-19 PrefaceSection A: SARS-CoV-2 and COVID-19: Introductory chapters and setting the scene1. Coronavirus disease 2019 (COVID-19) pandemic in context: Systemic effects2. Early warning of SARS-CoV-2 infection3. Mobile phones and their use to study dynamics of the COVID-19 pandemicSection B: Structure, transmission and avoidance4. Cis regulatory elements: A novel communication route between the host cell and the SARS-CoV-2 genome5. SARS-CoV-2 ORF8: Structure, evolution, molecular function, and its contribution to thepathogenicity of the virus6. SARS-CoV-2 spike protein binding ligands and its application in COVID-19 therapeutics7. SARS-CoV-2 bulldozes the autophagy pathway and unhinges mitochondrial quality controlthereby driving neurodegeneration-A hypothesis8. The Omicron variant of SARS-CoV-29. Monitoring SARS-CoV-2 spread in hospitals10. Computational analysis of mutations in SARS-CoV-2 variants spike protein and proteininteractions11. Airborne transmission of SARS-CoV-212. Reducing transmission of SARS-CoV-2 with face masks: Its potential protective effects13. Digital twin of ventilation system against COVID-19 transmission and infection risk14. Pets and SARS-CoV-2: What is their role in the epidemiology of the disease?15. SARS-CoV-2 transmission in dental practice16. SARS-CoV-2 compared with influenza and respiratory syncytial virus in terms of verticaltransmission17. Reducing droplets and aerosols in the surgical setting and applications to the COVID-19pandemic18. SARS-CoV motion dynamics: Linking in droplet size19. Ventilation and airborne particles in classrooms: Implications for the COVID-19 pandemic20. Indoor transmission of the SARS-CoV-2 virus through aerosols emitted by e-cigarettesSection C: Impact and effects21. The Impact of COVID-19 on first responders22. COVID-19 and suspected drug-induced liver injury23. Pulmonary fibrosis in COVID-1924. The effect of SARS-CoV-2 infection on cancer: Clinical correlation andpotential pathological mechanism25. Severe SARS-CoV-2, plateletendothelium interactions, and cardiovascular injury26. Cardiometabolic syndrome and COVID-19: Pathophysiological aspects27. COVID-19 and type 1 and 2 diabetes: An overview28. COVID-19 and older adults: An overview29. COVID-19 and male fertility30. COVID-19 and obesity: An overviewSection D: Treatments, strategies, and vaccines31. COVD-19 vaccines and their impact: An overview32. Exploring the promise of COVID-19 vaccines: A review of preclinical studies33. Drugs actively being investigated for use in COVID-1934. The biology of neutralizing antibody therapy with REGEN-COV35. The intensive care unit and percutaneous tracheostomy in patients with coronavirus disease201936. Cardiac effects of drugs and vaccines used to treat and prevent COVID-1937. COVID-19 pandemic and isolation: Impact on sleep38. Strategies in the COVID-19 pandemic: Disinfection of gloved hands39. In silico studies on established antivirals on SARS-CoV-2 RNAdependent RNA polymerase40. The COVID-19 cytokine storm and its immunomodulatory treatment41. Safety and efficacy of nebulization for reducing the intensity of viral load and clinical manifestations in patients with COVID-19Section E: Detection and biomarkers42. Bronchoalveolar lavage (BAL) and use in detection of SARS-CoV-243. SARS-CoV-2 testing and vaccination among people who use drugs44. Homocysteine as a biomarker in COVID-1945. Assessment of smell and taste in COVID-1946. S-gene analysis: RT-PCR and Sanger sequencing applied to SARS-CoV-2 virus47. False-negative results in screening for SARS-CoV-248. Sample pooling and SARS-CoV-2 assays49. Biomarkers of invasive mechanical ventilation in obesity and metabolic syndrome in patientswith COVID-19Section F: Case studies with mini review50. Hypoxia and heart-lung interactions in COVID-19: The significance of right heart dysfunction and shunt51. Ulnar nerve dysfunction as COVID-19 sequelae52. Case study: Coronavirus disease 2019 and acute kidney injury53. Case study: The detection and treatment of a pneumothorax in a patient with coronavirus disease 2019 pneumonia54. Proposal and demonstration of a survey method for the prevention of airborne transmission: Case studies in healthcare and welfare facilitiesSection G: Resources55. Recommended resources for the features, transmission, and detection of coronavirus disease2019 (COVID-19) International and Life Course Aspects of COVID-19 PrefaceSection A: Introductory chapters and setting the scene1. COVID-19 and mortality in children2. Congenital and perinatal COVID-19: Diagnostic challenges, current management, andoutcomes3. COVID-19 vaccine strategies4. Social and community responses to public health and social measures for COVID-19: Community engagement for risk preparednessSection B: International aspects5. The COVID-19 pandemic in Italy: Ecological background and epidemiological dynamics6 COVID-19 pandemic in Nigeria7. A bird's eye view of the COVID-19 pandemic in India: The past, present, and future8. COVID-19 pandemic in Europe Malgorzata Gruchola and Malgorzata9. COVID-19 in Latin America and the Caribbean (LAC)10. COVID-19 in Sudan: A multiperspective review11. Asymptomatic infection by SARSCoV-2 at the beginning of the epidemic in Cuba: Evidence fromcase series12. Stress and anxiety due to COVID-19 in India13. COVID-19 pandemic in Korea: A focus on medical management14. Stigma experienced by healthcare workers during the COVID-19 pandemic: Global and EgyptianperspectivesSection C: Reproduction, pregnancy and new-borns15. The COVID-19 pandemic and breastfeeding16. Impact of SARS-CoV-2 infection on female fertility17. Fetal death due to maternal COVID-1918. The COVID-19 pandemic and identification of SARS-CoV-2 in the prostate19. COVID-19 in pregnant women: Clinical course, treatment, and maternal/fetal outcome of vaccination during pregnancy20. Impact of the COVID-19 pandemic: SARS-CoV-2-specific IgG antibodies and their verticaltransfer21. COVID-19 vaccination during lactation22. Being pregnant during the COVID-19 pandemic: Impact of the trimester of gestation and measures of maternal mental health23. COVID-19 related maternal mortality and SARS-CoV-2 variants24. COVID-19-associated complications in pregnant women and neonates25. SARS-CoV-2 and its impact on the developing fetal neurologic system26. Impact of maternal SARS-CoV-2 infection in the placentaSection D: Children and adolescents27. T cells and their subsets in children with COVID-1928. Pediatric inflammatory multisystem syndrome and SARS-CoV-229. Impact of COVID-19 pandemic on nutritional status of children30. COVID-19 in children: Nutrition care31. Eating disorders in children during the COVID-19 pandemic32. Body composition in children with SARS-CoV-2 infection: Short and long term consequences33. Risk of SARS-CoV-2 infection and childhood obesity34. The impact of the COVID-19 pandemic during the lockdown and the post-COVID-19 effects onthe family system of children with disabilities35. The impact of the COVID-19 pandemic on ordinary vaccination programs for very young children: BCG, MMR, poliomyelitis, and beyond36. Immune responses to SARS-CoV-2 infection and vaccination in children37. The impact of the COVID-19 pandemic: How physical fitness changes in children38. The COVID-19 pandemic and children: Impact on physical activity39. The COVID-19 pandemic and stress related to schooling40. Suicidal thoughts and behaviors among adolescents during the COVID-19 pandemic41. The COVID-19 pandemic: Attending to hand hygiene measures in young people(a review of different studies)42. Child and adolescent COVID-19 vaccination: Trends, hesitancy, and strategies for increasing vaccination43. Social distancing behavior and mental health in US adolescents during the COVID-19 pandemic44. Thrombotic complications in children and adolescents with SARS-CoV-2 infection45. Features of SARS-CoV-2 infection and vaccination in children: A focus on magnetic resonance imaging of the heart46. SARS-CoV-2 infection and the cytokine levels and pathway in children: An updated narrativeSection E: Older adults47. Risk factors related to COVID-19 among older adults48. Reducing loneliness and social isolation among the elderly during the COVID-19 pandemic49. Features and measures of depression in the elderly and the impact of the COVID-19pandemic: Linking in preexisting mental health50. Experiences of disabled older adults in adult day care centers during the COVID-19 pandemic51. Using single-cell analysis to investigate disease severity in elderly patients with COVID-1952. COVID-19 and older adult food practices: A social determinants of health perspective53. Older subjects and immunogenicity of mRNA COVID-19 vaccines54. Noninvasive respiratory support in octogenarian patients with COVID-19Section F: Case studies with mini review55. Case study: COVID-19 severity in diabetic patients with and without seizure56. Case study: Nonpharmaceutical interventions for COVID-19 and their social impact in Japan57. Case study: Factors affecting vaccine uptake-Australian perspectives58. The impact of the COVID-19 pandemic on an older disabled person59. COVID-19 in the newborn: Clinical course and effects of maternal vaccination in pregnancySection G: Resources60. Recommended resources for the international and life course aspects of coronavirus disease 2019 (COVID-19) Linking Neuroscience and Behavior in COVID-19 PrefaceSection A: Introductory chapters and setting the scene1. The historical aspects of the SARS-CoV-2 virus and the ensuing pandemic2. Different variants of SARS-CoV-23. Lateral flow assay for SARS-CoV-2 infection: Uses and limitations4. Linking community participation, mobility disabilities, and the COVID-19 pandemic5. Influence of the sources used to obtain information on COVID-19 and their impact on mental healthSection B: Impact on behavior and psychology6. The psychological experiences and distress of defined populations in the COVID-19 pandemic: Doctors7. Impact of COVID-19 on behavior in autism spectrum disorder8. Prepandemic stressors in mental health responses to the COVID-19 pandemic: Early life adversities and beyond9. Compulsive hoarding in the COVID-19 pandemic10. The psychological experiences and distress in Japan and Sweden during the COVID-19 pandemic11. The COVID-19 pandemic, mental health, and sleep: Linking depression, anxiety, and perceivedstress12. The Covid-19 pandemic and the occupational overload of health professionals: Indicators ofburnout13. Neurocognitive sequelae of SARS-CoV-2 infection: Pathogenesis, risk factors, assessment, and implications14. Acute neurocognitive disorder as a presenting manifestation of COVID-1915. Mental health and the impact of confinement16. Cannabis use in the COVID-19 pandemic: Changes in different populations and implicationsfor policy17. Impact of COVID-19 on mental health in women: Socioeconomic groups and global aspects18. Quality of life assessment of patients after COVID-1919. COVID-19 pandemic and remote working: Toward a new way of working20. Long COVID and its persistence: A focus on mental health21. The impact of the COVID-19 pandemic on behavioral and psychological features of vulnerable groups: Patients with multiple sclerosis and their quality of lifeSection C: Effects on neurological structures and mechanisms23. Linking pediatric COVID-19 with basal ganglia and dentate nucleus24. Sensory disorders, neuroinflammation, and COVID-1925. The effects of COVID-19 isolations on nonmotor features of Parkinson's disease26. Myelitis following COVID-19: The road so far27. The corpus callosum: Effects due to SARS-CoV-2 infection and the mRNA vaccine28. Assessing the impact of prenatal SARS-CoV-2 exposure on infants' neurodevelopment: A comprehensive analysis of current evidence29. Electroencephalographic features with COVID-1930. Survivors of COVID-19 and clinical neuropsychological domain characteristics31. Neuroinflammation following SARS-CoV-2 infection32. Functional magnetic resonance imaging and depressive symptoms in subjects with COVID-1933. Impact of COVID-19 on the brain: Antibodies against brain stem antigens34. The kynurenine pathway and role in mental health of post-COVID-19 patientsSection D: Management, support and treatments35. Management of brain tumors in the COVID-19 pandemic36. The impact of the COVID-19 pandemic on ischemic stroke management: From hyperacute to chronic phase37. Long COVID and the potential use of palmitoylethanolamide38. Cognitive assessments in post-COVID syndrome: A focus on the neuropsychological tests andprotocols39. Supporting individuals with intellectual and developmental disabilities during the COVID-19pandemic40. Preserving well-being and quality of life through school-based interventions focused on physicalactivity during the COVID-19 pandemic41. Hesitancy in using COVID 19 prevention behaviors among African Americans: Strategies tobuild confidence42. New strategies for psychological well-being at work43. Mitigating mental health changes with virtual reality technology during Covid-19: A narrative44. Music therapy for patients with neurological disorders during COVID-19 pandemic45. Mental health and the modulating effects of receiving the COVID-19 vaccination46. Personalized cognitive behavioral therapy on patients with obesity in COVID-19 pandemic47. Social anxiety disorder and Covid 19: Treatment with cognitive behavioral therapy48. Burnout during the COVID-19 pandemic: Modulating role of mindfulnessSection E: Case studies with mini review49. Case study: Evaluation of a long Covid assessment service (LCAS)50. Case study: Navigating youth mental health and addictions care in the context of the COVID-19 pandemic51. Case study: Restless leg syndrome associated with COVID-19Section F: Resources52. Recommended resources for linking neuroscience and behavior in coronavirus disease(COVID-19) Management, Body Systems, and Case Studies in COVID-19 PrefaceSection A: Introductory chapters and setting the scene1. Hand hygiene strategies2. Approved vaccines for the COVID-19 pandemic: Linking in future perspectives3. Molecular methods for SARS-CoV-2 variant detectionSection B: Management4. Systematic patient assessment for acute respiratory tract ailments (SPARTA): A simple tool to improve outcomes from COVID-195. Point of care ultrasound for coronavirus disease 2019: The multiorgan approach to COVID-196. COVID-19 in patients with inflammatory bowel diseases: Features and guidelines7. Management of COVID-19 and clinical nutrition8. The management of head and neck cancer in COVID-199. The COVID-19 pandemic: Inventory management and allocation of personal protectiveequipment10. Clinical management in the COVID-19 pandemic: Rheumatic disease11. Managing migraines during the COVID-19 pandemic: An Italian experience12. Managing acute ischemic stroke in the SARS-CoV-2 pandemic13. Impact of the coronavirus disease 2019 pandemic on patients with hypertension14. Neurosurgical trauma management during COVID-19 restrictions15. The COVID-19 pandemic and management of weight gain: Implications for obesity16. COVID-19 and the management of heart failure using telemedicineSection C: Guidelines for different treatment clinics17. Guidelines for breast imaging in the COVID-19 pandemic18. Vaccine-induced (immune) thrombotic thrombocytopenia (VITT): Diagnosis, guidelines,and reporting19. Lung cancer in the era of COVID-1920. Multisystem inflammatory syndrome in children/pediatric inflammatory multisystemsyndrome: Clinical guidelinesSection D: Impact on the respiratory system21. Ground-glass nodules in the lungs of COVID-19 patients22. Cardiothoracic imaging in patients affected by COVID-1923. Cystic fibrosis and bronchial epithelial cells in SARS-CoV-2 infection24. Biomechanics and mechanobiology of the lung parenchyma following SARS-CoV-2 infection25. Long noncoding RNA profiling in respiratory specimens from COVID-19 patients26. COVID-19 and acute pulmonary embolism27. The usefulness of the alveolar-arteriolar gradient during the COVID-19 pandemicSection E: Effects on cardiovascular and hematological systems28. Cardiac manifestations of COVID-19: An overview29. Limb ischemia and COVID-1930. Thrombosis and coagulopathy in COVID-19: A new narrative31. COVID-19 myocarditis: Features of echocardiography32. COVID-19 lockdown and impact on arrhythmias33. Cardiometabolic disease and COVID-19: A new narrative34. Postrecovery COVID-19 and interlinking diabetes and cardiovascular events35. COVID-19 patients and extracorporeal membrane oxygenation36. Sars-CoV-2 infection in different hematological patientsSection F: Effects on body systems37. Dermatological reactions associated with personal protective equipment use duringthe COVID-19 pandemic38. Hemodialysis patients, effects of infections by SARS-CoV-2 and vaccine response39. Coinfections with COVID-19: A focus on tuberculosis (TB)40. Patients with autoimmune liver disease and the impact of Sars-COV-2 infection41. COVID-19 severity and nonalcoholic fatty liver disease42. Changes in obesity and diabetes severity during the COVID-19 pandemic at VirginiaCommonwealth University health system43. The diabetic patient and concomitant conditions rhinoorbital-cerebral mucormycosisand COVID-1944. Tissue location of SARS-CoV-2 RNA: A focus on bone and implications for skeletal health45. Linking between gastrointestinal tract effects of COVID-19 and tryptophan metabolism46. Organ damage in SARS-CoV-2 infection in children: A focus on acute kidney injury47. Obesity, COVID-19 severity, and mortality48. Upper and lower gastrointestinal symptoms and manifestations of COVID-1949. The COVID-19 survivors: Impact on skeletal muscle strengthSection G: Case studies with mini review50. A case report: COVID-19 meningoencephalitis and intracranial hemorrhage51. Case study: Oral mucosal lesions in patients with COVID-1952. Case study: COVID-19 pneumonia presented with cavitary lesions53. Case study: Optic neuritis in SARS-CoV-2 infectionSection H: Resources54. Recommended resources relevant to the body systems involvementand management of COVID-19

• ISBN: 978-0-443-18831-2
• Editorial: Academic Press
• Encuadernacion: Cartoné
• Páginas: 600
• Fecha Publicación: 01/06/2024
• Nº Volúmenes: 1
• Idioma: Inglés